Ansel Johnson, OD
Optometrist · Blue Island, ILNPI 1023106309
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by LKC Technologies, Inc. at 24.9% of the total. Among optometrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $64.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LKC Technologies, Inc.$4K
- Tarsus Pharmaceuticals, Inc.$3K
- AbbVie$1K
- Alcon$1K
- GSK$1K
- Sight Sciences, Inc.$778
- plus $4K from 20 others
Across 50 payments — averaging $2384.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$119K
What the payments were for
- Consulting fees$3,27521%
- Speaking & faculty fees$4,49529%
- Food & beverage$7,54149%
- Education$250%
- Entertainment$1261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LKC Technologies, Inc. | 6 | $3,850 |
| Tarsus Pharmaceuticals, Inc. | 23 | $3,179 |
| AbbVie(2 entities) | 68 | $1,476 |
| Alcon | 30 | $1,248 |
| GSK | 1 | $1,095 |
| Sight Sciences, Inc. | 7 | $778 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 27 | $670 |
| Johnson & Johnson Vision Care, Inc. | 12 | $649 |
| Bausch & Lomb Americas Inc. | 18 | $541 |
| Biotissue Holdings Inc. | 8 | $316 |
| Sun Pharmaceutical Industries Inc. | 6 | $290 |
| Visioneering Technologies, Inc. | 2 | $280 |
| Rxsight Inc | 3 | $233 |
| Dompe US, Inc. | 8 | $232 |
| Optos, Inc. | 4 | $126 |
| Coopervision Inc. | 3 | $122 |
| Dexcom, Inc. | 1 | $91 |
| Maculogix, Inc. | 1 | $73 |
| Shire North American Group Inc | 2 | $55 |
| Topcon Healthcare, Inc. | 1 | $51 |
| Aerie Pharmaceuticals, Inc. | 1 | $23 |
| Vyera Pharmaceuticals, LLC | 2 | $23 |
| Tearlab Corp | 1 | $18 |
| Novartis | 1 | $18 |
| ABB Con-cise Optical Group LLC | 1 | $16 |
| Quidel Corporation | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XDEMVY$1,712
- BLENREP$1,095
- OMNI(R) SURGICAL SYSTEM (US)$622
- Acuvue$338
- Precision 1$195
- TOTAL30$146
- DAILIES$130
- RXSIGHT CONTACT LENS$125
- RXSIGHT INJECTOR CARTRIDGE$125
- RXSIGHT INJECTOR HANDPIECE$125
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$125
- LIGHT ADJUSTABLE LENS (LAL)$125
- RESTASIS$124
- CEQUA$124
- INFUSE$121
- Prokera$115
- AmnioGraft$115
- TearCare$112
- Precision7$105
- LUMIGAN$101
How this compares
$15,461 in reported general payments places this provider in the 95th percentile of 2,257 optometrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XdemvyLotilaner | 63 | $118,544 |
| LumiganBimatoprost | 74 | $47,194 |
| CombiganBrimonidine Tartrate/Timolol | 40 | $13,917 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 23 | $3,738 |
| Latanoprost | 128 | $2,791 |
| BesivanceBesifloxacin Hcl | 11 | $2,357 |
| Travoprost | 15 | $1,402 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 38 | $697 |
| Prednisolone Acetate | 24 | $625 |
| Dorzolamide Hcl | 27 | $586 |
| Brimonidine Tartrate | 11 | $495 |
| Ketorolac Tromethamine | 26 | $267 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Tarsus Pharmaceuticals, Inc.Xdemvy | $3,179 | $118,54463 claims |
| AbbVieLumigan, Combigan | $1,476 | $61,111114 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCBesivance | $670 | $2,35711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,257 optometrist providers in Illinois.
Other optometrist in Blue Island
- Pamela LoweChicago$447K
- Jeffrey LewisChampaign$394K
- Adeyinka AdewaleGodfrey$391K
- Michael ChaglasianChicago$367K
- Jessilin QuintChicago$366K
- Jullian CerasuoloChicago$329K
- Steven EidenDeerfield$259K
- Peter KehoeGalesburg$167K
- Gulroop HansraDowners Grove$151K
- Treacy AdamoHinsdale$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.